T Lindl
Overview
Explore the profile of T Lindl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hahlbrock K, Kuhlen E, Lindl T
Planta
. 2014 Feb;
99(4):311-8.
PMID: 24487682
1. A typical growth curve including a lag phase, phases of cell division and cell expansion and a stationary phase could be demonstrated for batch propagated cells ofGlycine max. in...
2.
Lindl T
Cytotechnology
. 2012 Feb;
21(3):183-93.
PMID: 22358750
This article describes the current status in the development of human monoclonal antibodies. Over the last ten years a lot of information about the human immune system has emerged. Combining...
3.
van der Valk J, Brunner D, De Smet K, Svenningsen A, Honegger P, Knudsen L, et al.
Toxicol In Vitro
. 2010 Apr;
24(4):1053-63.
PMID: 20362047
Quality assurance is becoming increasingly important. Good laboratory practice (GLP) and good manufacturing practice (GMP) are now established standards. The biomedical field aims at an increasing reliance on the use...
4.
Lindl T, Weichenmeier I, Labahn D, Gruber F, Volkel M
ALTEX
. 2001 Sep;
18(3):171-8.
PMID: 11565051
As a follow-up to our recent study about the suffering of laboratory animals in experiments, we investigated if results obtained from animal experiments performed in accordance with the German animal...
5.
Jakob R, Lindl T
Zentralbl Hyg Umweltmed
. 1990 Dec;
190(5-6):536-46.
PMID: 2127893
A computer controlled bench-top analyser was used to establish an automated in vitro-cytotoxicity test. It is based on the continuous monitoring of growth of Salmonella typhimurium TA 98 and TA...
6.
Binder S, Beutel M, Lindl T
Zentralbl Veterinarmed B
. 1990 Nov;
37(9):696-700.
PMID: 2267892
The examinations show, that it is possible to adapt MDBK-cells (ATCC CCL 22) to serum-poor (0.1% fetal calf serum) and to serum-free, adequate supplemented media. Morphology of the cells remained...
7.
Gebauer W, Lindl T
Arzneimittelforschung
. 1990 Jun;
40(6):718-22.
PMID: 2168706
A human monoclonal antibody against Rabies NS-protein was developed using peripheral blood lymphocytes. A special immunization protocol was used in order to achieve maximal cell numbers of active secreting B...
8.
Gebauer W, Lindl T
Blut
. 1990 May;
60(5):301-3.
PMID: 2350594
Urinary glycoprotein patterns from leukemic patients and from healthy donors were found to be identical, when the detection was carried out with the same quantities of protein. Two dimensional polyacrylamide...
9.
Gebauer W, Lindl T
Arzneimittelforschung
. 1989 Feb;
39(2):287-91.
PMID: 2659004
The "state of the art" in the development of human monoclonal antibodies is reported. The classical cellular fusion method according to well established procedures, the Epstein-Barr virus mediated B-lymphocyte transformation...
10.
Jirikowski G, Lindl T, Seliger H
Histochemistry
. 1989 Jan;
91(1):51-3.
PMID: 2925447
A synthetic oligonucleotide probe, complementary to oxytocin m-RNA was labelled enzymatically with 5-bromo-2'-deoxyuridine (5-BrdU) and with [gamma-32P]-ATP. The labelled probes were used for in situ hybridization of histological sections of...